Clinical Trial Update: JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for JSKN033 in advanced cervical cancer, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• JSKN033

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Cervical Cancer | Phase 2 | Status: NOT_YET_RECRUITING